These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30222141)

  • 21. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.
    Heffron R; Parikh UM; Penrose KJ; Mugo N; Donnell D; Celum C; Mellors JW; Baeten JM;
    AIDS Behav; 2017 Jul; 21(7):2173-2179. PubMed ID: 27699594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.
    Dabee S; Balle C; Onono M; Innes S; Nair G; Palanee-Phillips T; Burgener AD; Bosinger SE; Passmore JS; Heffron R; Jaspan H; Happel AU
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):251-260. PubMed ID: 37341916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
    Huijbregts RP; Michel KG; Hel Z
    Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
    mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
    Quispe Calla NE; Vicetti Miguel RD; Torres AR; Trout W; Gabriel JM; Hatfield AM; Aceves KM; Kwiek JJ; Kaur B; Cherpes TL
    Immunohorizons; 2020 Feb; 4(2):72-81. PubMed ID: 32047094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.
    Chandra N; Thurman AR; Anderson S; Cunningham TD; Yousefieh N; Mauck C; Doncel GF
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):592-601. PubMed ID: 23189932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
    Quispe Calla NE; Vicetti Miguel RD; Boyaka PN; Hall-Stoodley L; Kaur B; Trout W; Pavelko SD; Cherpes TL
    Mucosal Immunol; 2016 Nov; 9(6):1571-1583. PubMed ID: 27007679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.
    Huijbregts RP; Helton ES; Michel KG; Sabbaj S; Richter HE; Goepfert PA; Hel Z
    Endocrinology; 2013 Mar; 154(3):1282-95. PubMed ID: 23354099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility.
    Woods MW; Zahoor MA; Dizzell S; Verschoor CP; Kaushic C
    Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29105931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
    Morrison C; Fichorova RN; Mauck C; Chen PL; Kwok C; Chipato T; Salata R; Doncel GF
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):109-17. PubMed ID: 24413042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.
    Mitchell CM; McLemore L; Westerberg K; Astronomo R; Smythe K; Gardella C; Mack M; Magaret A; Patton D; Agnew K; McElrath MJ; Hladik F; Eschenbach D
    J Infect Dis; 2014 Aug; 210(4):651-5. PubMed ID: 24652495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
    AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix.
    Edfeldt G; Lajoie J; Röhl M; Oyugi J; Åhlberg A; Khalilzadeh-Binicy B; Bradley F; Mack M; Kimani J; Omollo K; Wählby C; Fowke KR; Broliden K; Tjernlund A
    J Infect Dis; 2022 Apr; 225(7):1151-1161. PubMed ID: 32780807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate.
    Civic D; Scholes D; Ichikawa L; LaCroix AZ; Yoshida CK; Ott SM; Barlow WE
    Contraception; 2000 Jun; 61(6):385-90. PubMed ID: 10958882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
    Weinberg A; Park JG; Bosch R; Cho A; Livingston E; Aweeka F; Cramer Y; Watts DH; Luque AE; Cohn SE
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):137-45. PubMed ID: 26413850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.